- Home
- PTGX vs MLCO Comparison
PTGX vs MLCO Comparison
Compare PTGX & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- MLCO
- Stock Information
- Founded
- PTGX 2006
- MLCO 2004
- Country
- PTGX United States
- MLCO Hong Kong
- Employees
- PTGX N/A
- MLCO N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- MLCO Hotels/Resorts
- Sector
- PTGX Health Care
- MLCO Consumer Discretionary
- Exchange
- PTGX Nasdaq
- MLCO Nasdaq
- Market Cap
- PTGX 2.9B
- MLCO 2.6B
- IPO Year
- PTGX 2016
- MLCO 2006
- Fundamental
- Price
- PTGX $47.47
- MLCO $6.28
- Analyst Decision
- PTGX Strong Buy
- MLCO Hold
- Analyst Count
- PTGX 8
- MLCO 5
- Target Price
- PTGX $66.50
- MLCO $7.06
- AVG Volume (30 Days)
- PTGX 789.1K
- MLCO 3.0M
- Earning Date
- PTGX 05-06-2025
- MLCO 05-08-2025
- Dividend Yield
- PTGX N/A
- MLCO N/A
- EPS Growth
- PTGX N/A
- MLCO N/A
- EPS
- PTGX 0.86
- MLCO 0.14
- Revenue
- PTGX $207,801,000.00
- MLCO $4,758,114,000.00
- Revenue This Year
- PTGX N/A
- MLCO $8.77
- Revenue Next Year
- PTGX $50.30
- MLCO $2.87
- P/E Ratio
- PTGX $55.04
- MLCO $44.08
- Revenue Growth
- PTGX N/A
- MLCO 14.07
- 52 Week Low
- PTGX $27.00
- MLCO $4.55
- 52 Week High
- PTGX $60.60
- MLCO $8.90
- Technical
- Relative Strength Index (RSI)
- PTGX 58.60
- MLCO 62.52
- Support Level
- PTGX $45.43
- MLCO $6.03
- Resistance Level
- PTGX $46.80
- MLCO $6.54
- Average True Range (ATR)
- PTGX 1.54
- MLCO 0.19
- MACD
- PTGX 0.34
- MLCO -0.01
- Stochastic Oscillator
- PTGX 94.26
- MLCO 49.02
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts and Entertainment Ltd is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao with the rest largely from the Philippines as of 2024.